Article Details

Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix[®] in the Czech Republic

Retrieved on: 2023-01-02 10:56:29

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix[®] in the Czech Republic. View article details on hiswai:

Excerpt

Hansa Biopharma announced that it has attained reimbursement in the Czech Republic for its first-in-class treatment, Idefirix®, ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up